Literature DB >> 11967342

Activation of NF-kappaB by R5 and X4 human immunodeficiency virus type 1 induces macrophage inflammatory protein 1alpha and tumor necrosis factor alpha in macrophages.

Wonkyu Choe1, David J Volsky, Mary Jane Potash.   

Abstract

NF-kappaB is a transcriptional activator that often regulates inflammatory responses. We demonstrate that human immunodeficiency virus type 1 activates nuclear localization of NF-kappaB in macrophages in a manner dependent upon virus strain but independent of virus replication. Through the use of an inhibitor, NF-kappaB activation was found to be responsible for the cytokine and chemokine induction that we recently reported.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11967342      PMCID: PMC136147          DOI: 10.1128/jvi.76.10.5274-5277.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  13 in total

1.  An efficient method for simultaneous isolation of biologically active transcription factors and DNA.

Authors:  L Caruccio; R Banerjee
Journal:  J Immunol Methods       Date:  1999-11-19       Impact factor: 2.303

Review 2.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

Review 3.  Induction of expression of HIV in latently or chronically infected cells.

Authors:  Z F Rosenberg; A S Fauci
Journal:  AIDS Res Hum Retroviruses       Date:  1989-02       Impact factor: 2.205

4.  NFkappaB activation, TNF-alpha expression, and apoptosis in the AIDS-Dementia-Complex.

Authors:  K Rostasy; L Monti; C Yiannoutsos; J Wu; J Bell; J Hedreen; B A Navia
Journal:  J Neurovirol       Date:  2000-12       Impact factor: 2.643

5.  Induction of rapid and extensive beta-chemokine synthesis in macrophages by human immunodeficiency virus type 1 and gp120, independently of their coreceptor phenotype.

Authors:  W Choe; D J Volsky; M J Potash
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

6.  C/EBP, NF-kappa B, and c-Ets family members and transcriptional regulation of the cell-specific and inducible macrophage inflammatory protein 1 alpha immediate-early gene.

Authors:  M Grove; M Plumb
Journal:  Mol Cell Biol       Date:  1993-09       Impact factor: 4.272

7.  Binding of human immunodeficiency virus type 1 to CD4 and CXCR4 receptors differentially regulates expression of inflammatory genes and activates the MEK/ERK signaling pathway.

Authors:  W Popik; J E Hesselgesser; P M Pitha
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

8.  Inactivation of lymphadenopathy-associated virus by heat, gamma rays, and ultraviolet light.

Authors:  B Spire; D Dormont; F Barré-Sinoussi; L Montagnier; J C Chermann
Journal:  Lancet       Date:  1985-01-26       Impact factor: 79.321

9.  Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression.

Authors:  G Poli; A Kinter; J S Justement; J H Kehrl; P Bressler; S Stanley; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

10.  Temporal gene regulation during HIV-1 infection of human CD4+ T cells.

Authors:  J Corbeil; D Sheeter; D Genini; S Rought; L Leoni; P Du; M Ferguson; D R Masys; J B Welsh; J L Fink; R Sasik; D Huang; J Drenkow; D D Richman; T Gingeras
Journal:  Genome Res       Date:  2001-07       Impact factor: 9.043

View more
  15 in total

Review 1.  Barriers for HIV Cure: The Latent Reservoir.

Authors:  Sergio Castro-Gonzalez; Marta Colomer-Lluch; Ruth Serra-Moreno
Journal:  AIDS Res Hum Retroviruses       Date:  2018-08-28       Impact factor: 2.205

2.  Macrophage colony stimulating factor regulation by nuclear factor kappa B: a relevant pathway in human immunodeficiency virus type 1 infected macrophages.

Authors:  Michael Kogan; Valerie Haine; Yuxong Ke; Brian Wigdahl; Tracy Fischer-Smith; Jay Rappaport
Journal:  DNA Cell Biol       Date:  2011-09-06       Impact factor: 3.311

3.  Phosphatidylcholine-specific phospholipase C activation is required for CCR5-dependent, NF-kB-driven CCL2 secretion elicited in response to HIV-1 gp120 in human primary macrophages.

Authors:  Laura Fantuzzi; Francesca Spadaro; Cristina Purificato; Serena Cecchetti; Franca Podo; Filippo Belardelli; Sandra Gessani; Carlo Ramoni
Journal:  Blood       Date:  2008-01-18       Impact factor: 22.113

Review 4.  Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage.

Authors:  Valentin Le Douce; Georges Herbein; Olivier Rohr; Christian Schwartz
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

5.  Chemokines and Chemokine Receptors Critical to Host Resistance following Genital Herpes Simplex Virus Type 2 (HSV-2) Infection.

Authors:  M Thapa; D J J Carr
Journal:  Open Immunol J       Date:  2008

6.  Inhibition of NF-κB activity by HIV-1 Vpr is dependent on Vpr binding protein.

Authors:  Michael Kogan; Satish Deshmane; Bassel E Sawaya; Edward J Gracely; Kamel Khalili; Jay Rappaport
Journal:  J Cell Physiol       Date:  2013-04       Impact factor: 6.384

Review 7.  Co-receptor signaling in the pathogenesis of neuroHIV.

Authors:  E A Nickoloff-Bybel; L Festa; O Meucci; P J Gaskill
Journal:  Retrovirology       Date:  2021-08-24       Impact factor: 4.602

8.  Molecular Understanding of HIV-1 Latency.

Authors:  W Abbas; G Herbein
Journal:  Adv Virol       Date:  2012-04-04

9.  Genome-wide prediction of transcriptional regulatory elements of human promoters using gene expression and promoter analysis data.

Authors:  Seon-Young Kim; YongSung Kim
Journal:  BMC Bioinformatics       Date:  2006-07-04       Impact factor: 3.169

10.  Identification of gene products suppressed by human immunodeficiency virus type 1 infection or gp120 exposure of primary human astrocytes by rapid subtraction hybridization.

Authors:  Zao-Zhong Su; Dong-Chul Kang; Yinming Chen; Olga Pekarskaya; Wei Chao; David J Volsky; Paul B Fisher
Journal:  J Neurovirol       Date:  2003-06       Impact factor: 3.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.